A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Clinical trial NCT06855160 · RECRUITING
Trial details
- NCT number
- NCT06855160
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-17
- Primary completion
- 2026-09-10
- Enrollment
- 911
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.